Trendlines Group Ltd. · SGX:42T

Trendlines — The Trendlines Group — Q1 2018 Earnings Presentation

17 slides from Trendlines's earnings presentation, May 10, 2018

  1. Slide 1: The Trendlines Group Financial Highlights Q1 2018

    The Trendlines Group Financial Highlights Q1 2018 Steve Rhodes Todd Dollinger Gabi Heller Chairman and CEO Chairman and CEO Chief Financial Officer May 2018 SGX:42T OTCQX: TRNLY

  2. Slide 2: Agenda

    Agenda • Corporate highlights • Financial highlights • Post Q1 2018 developments 2

  3. Slide 3: Legal disclaimer

    Legal disclaimer Important notice This presentation is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any securities of The Trendlines Group Ltd. (“Company”) or any of its portfo

  4. Slide 4: Corporate highlights

    Corporate highlights

  5. Slide 5: 10 years of portfolio value expansion

    10 years of portfolio value expansion US$ millions Portfolio value with exit proceeds 140 120 Portfolio value* 100 Cumulative exit proceeds 80 60 40 20 0 30.12.08 30.12.09 30.12.10 30.12.11 31.12.12 31.12.13 31.12.14 31.12.15 31.12.16 31.12.17 31.3.18 *Portfolio value includes the fair value of inve

  6. Slide 6: Key financial developments Q1 2018

    Key financial developments Q1 2018 31 March 2018 31 December 2017 Change % Change Portfolio value US$ 97.4 million US$ 96.8 million + US$ 0.6 million +0.6% Book value US$ 91.5 million US$ 92.9 million - US$ 1.4 million -1.5% Current assets US$ 18 million US$ 20.4 million - US$ 2.4 million -12% 31 Ma

  7. Slide 7: Focus on cash flow

    Focus on cash flow Total Cash from Operations (US$ millions) $7 5.9 $6 $5 $4 3.8 3.6 3.5 3.3 2.9 $3 2.6 2.5 2.3 $2 1.5 $1 $0 2012 2013 2014 2015 2016 2017 2018 2019 Cash from Operations 3-year Moving Average Linear (3-year Moving Average) 7

  8. Slide 8: Q1 2018 developments

    Q1 2018 developments • Trendlines Medical Singapore Pte. Ltd. and K2 Global Pte. Ltd. to participate in the Singapore government’s SGD100 million SPRING SEEDS Capital start-up investment program • Trendlines and Nutreco Investments B.V. signed collaboration MOU • One new medical portfolio company es

  9. Slide 9: 10 companies (+1) to watch

    10 companies (+1) to watch* • ApiFix Ltd. • Leviticus Cardio Ltd. • BioFishency Ltd. • MemTech Ltd. • EdenShield Ltd. • Saturas Ltd. • Fidmi Medical Ltd. • STS Medical Ltd. • Gordian Surgical Ltd. • Vensica Medical Ltd. +1 Stimatix GI Ltd. *Updated report issued: 23 April 2018 9

  10. Slide 10: Q1 highlights from the "10 Companies to Watch" report

    Q1 highlights from the “10 Companies to Watch” report • ApiFix Ltd. and Gordian Surgical Ltd. completed >200 surgeries • BioFishency Ltd. reached US$800,000 in sales in Q1 2018 • EdenShield Ltd. increased installations 3X in Q1 2018 • Leviticus Cardio Ltd. announced animal trial with successful 60+

  11. Slide 11: Financial highlights

    Financial highlights

  12. Slide 12: Consolidated condensed report of income

    Consolidated condensed report of income 12

  13. Slide 13: Key value components

    Key value components Change in portfolio value during quarter Balance sheet (US$ millions) 18 (4) (5.1) (13.8) 2.3 (1.7) (1) 96.8 97.4 91.5 Net portfolio Investments Fair value Net portfolio Cash, short- Fair value of Deferred Deferred tax** Payables & Total equity value 31.12.17 and new decrease &

  14. Slide 14: Post Q1 2018 developments

    Post Q1 2018 developments

  15. Slide 15: Post Q1 2018 developments

    Post Q1 2018 developments • Disclosure of Stimatix GI Ltd. as Most Valuable Portfolio Company (“MVP”) and acquirer as B. Braun Medical SAS • ElastiMed Ltd. received approval of US$1.6 million grant from Horizon 2020 program • Over 500 people attended the AgriVest 2018 conference 15

  16. Slide 16: MIXii Biomed 2018

    MIXii Biomed 2018 15 -17 May 2018 | Tel Aviv, Israel http://kenes-exhibitions.com/biomed/ 16

  17. Slide 17: SGX: 42T OTCQX: TRNLY www.trendlines.com

    SGX: 42T Steve Rhodes, Chairman & CEO OTCQX: TRNLY steve@trendlines.com Todd Dollinger, Chairman & CEO +972.72.260.7000 todd@trendlines.com www.trendlines.com Gabi Heller, Chief Financial Officer gabi@trendlines.com 10 May 2018

The Trendlines Group — Q1 2018 Earnings Presentation on 6ix